Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis

被引：0
|
作者：
Hee-Young Yoon
Sojung Park
Dong Soon Kim
Jin Woo Song
机构：
[1] University of Ulsan College of Medicine,Department of Pulmonary and Critical Care Medicine, Asan Medical Centre
来源：
Respiratory Research | / 19卷
关键词：
Idiopathic pulmonary fibrosis; Respiratory function tests; Nintedanib; Treatment outcome; Adverse effects;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis
    Park, Sojung
    Lee, Jisun
    Kim, Dong Soon
    Song, Jin Woo
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [2] Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis
    Yoon, Hee-Young
    Park, Sojung
    Kim, Dong Soon
    Song, Jin Woo
    RESPIRATORY RESEARCH, 2018, 19
  • [3] Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
    Luca Richeldi
    Martin Kolb
    Stéphane Jouneau
    Wim A. Wuyts
    Birgit Schinzel
    Susanne Stowasser
    Manuel Quaresma
    Ganesh Raghu
    BMC Pulmonary Medicine, 20
  • [4] Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
    Richeldi, Luca
    Kolb, Martin
    Jouneau, Stephane
    Wuyts, Wim A.
    Schinzel, Birgit
    Stowasser, Susanne
    Quaresma, Manuel
    Raghu, Ganesh
    BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [5] Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
    Richeldi, Luca
    du Bois, Roland M.
    Raghu, Ganesh
    Azuma, Arata
    Brown, Kevin K.
    Costabel, Ulrich
    Cottin, Vincent
    Flaherty, Kevin R.
    Hansell, David M.
    Inoue, Yoshikazu
    Kim, Dong Soon
    Kolb, Martin
    Nicholson, Andrew G.
    Noble, Paul W.
    Selman, Moises
    Taniguchi, Hiroyuki
    Brun, Michele
    Le Maulf, Florence
    Girard, Mannaig
    Stowasser, Susanne
    Schlenker-Herceg, Rozsa
    Disse, Bernd
    Collard, Harold R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (22): : 2071 - 2082
  • [6] Efficacy and Safety of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis: An Update
    Antonio Rodriguez-Portal, Jose
    DRUGS IN R&D, 2018, 18 (01) : 19 - 25
  • [7] Efficacy and Safety of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis: An Update
    José Antonio Rodríguez-Portal
    Drugs in R&D, 2018, 18 : 19 - 25
  • [8] Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Multiple Comorbidities
    Glaspole, I.
    Bonella, F.
    Bargagli, E.
    Glassberg, M. K.
    Caro, F.
    Stansen, W.
    Quaresma, M.
    Orsatti, L.
    Bendstrup, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [9] Nintedanib - efficacy, safety and practical aspects of treatment for patients with idiopathic pulmonary fibrosis
    Martusewicz-Boros, Magdalena
    Gorska, Katarzyna
    ADVANCES IN RESPIRATORY MEDICINE, 2020, 88 (06) : 599 - 607
  • [10] The Safety and Efficacy of Nintedanib at Various Doses in Idiopathic Pulmonary Fibrosis: A Retrospective Study
    Chou, C.
    Liao, T.
    Wang, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
12345